Allergan agrees to obtain KYTHERA Biopharmaceuticals for $2.1 billion Allergan plc , a respected global pharmaceutical firm, and KYTHERA Biopharmaceuticals, Inc. , a biopharmaceutical company focused on the discovery, commercialization and development of novel prescription products for the aesthetic medicine market, today announced that they have entered right into a definitive agreement under which Allergan
Continue reading Allergan agrees to obtain KYTHERA Biopharmaceuticals for $2.